No variable specified
Sanuwave in Alpharetta appoints new life sciences executive
by Staff
September 11, 2013 10:33 AM | 901 views | 0 0 comments | 1 1 recommendations | email to a friend | print
Sanuwave Health Inc. recently announced the appointment of Alan L. Rubino to the company’s board of directors. Rubino has more than 30 years of experience at every level of the biopharmaceutical industry, including positions focused on sales and marketing and SEC matters. With this appointment, the company’s board has four members.

“We are delighted to welcome Alan to our board of directors,” said Kevin A. Richardson, chairman of the board of directors of Sanuwave.

“Throughout his career, Rubino has developed a strong network of industry experts including medical device distributors. His industry knowledge and strong relationships with companies that are addressing chronic diabetes issues will be of great value to Sanuwave. We look forward to benefiting from his guidance as we work diligently to advance Sanuwave and create shareholder value.”

Rubino has served as president and chief executive officer of Emisphere Technologies, Inc. since September 2012. Previously, Rubino served as the CEO and president of New American Therapeutics, Inc., CEO and president of Akrimax Pharmaceuticals LLC and president and COO of Pharmos Corporation.

Commenting on his appointment, Rubino said, “I am most enthusiastic about joining the company’s board of directors at this time. Sanuwave represents a compelling growth opportunity with the dermaPACE Phase III clinical trial underway in the U.S. and the on-going use of the dermaPACE and orthoPACE devices outside the United States. I look forward to working with the management team to expand the international distribution of their medical devices and to develop value-enhancing strategies to compete in multiple large market opportunities.”

Comments
(0)
Comments-icon Post a Comment
No Comments Yet
*We welcome your comments on the stories and issues of the day and seek to provide a forum for the community to voice opinions. All comments are subject to moderator approval before being made visible on the website but are not edited. The use of profanity, obscene and vulgar language, hate speech, and racial slurs is strictly prohibited. Advertisements, promotions, spam, and links to outside websites will also be rejected. Please read our terms of service for full guides